K Takeyama
About
In The Last Decade
K Takeyama
31 papers receiving 620 citations
Peers
Comparison fields: 5 of 72
- Hematology 230
- Oncology 217
- Molecular Biology 194
- Genetics 138
- Pathology and Forensic Medicine 109
Countries citing papers authored by K Takeyama
This map shows the geographic impact of K Takeyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Takeyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Takeyama more than expected).
Fields of papers citing papers by K Takeyama
This network shows the impact of papers produced by K Takeyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Takeyama. The network helps show where K Takeyama may publish in the future.
Co-authorship network of co-authors of K Takeyama
This figure shows the co-authorship network connecting the top 25 collaborators of K Takeyama. A scholar is included among the top collaborators of K Takeyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Takeyama. K Takeyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 8 | |
| 3 | 23 | |
| 4 | 25 | |
| 5 | 72 | |
| 6 | 20 | |
| 7 | 3 | |
| 8 | [Therapy-related leukemia and myelodysplastic syndrome: a multi-institution study in Japan]. | 1 |
| 9 | 9 | |
| 10 | Possible involvement of ATP-dependent K-channel related mechanisms in the antihypertensive and cough suppressant effects of the novel ACE inhibitor (2S, 3aS, 7aS)-1-(N2-nicotinoyl-L-lysyl-gamma-D-glutamyl)octahydro-1H- indole-2-carboxylic acid. | 3 |
| 11 | 13 | |
| 12 | 108 | |
| 13 | 99 | |
| 14 | Low-dose granulocyte colony-stimulating factor enables the efficient collection of peripheral blood stem cells after disease-oriented, conventional-dose chemotherapy for breast cancer, malignant lymphoma and germ cell tumor. | 12 |
| 15 | 4 | |
| 16 | Comparison between bone marrow transplantation and immuno-suppressive therapy in treatment of patients younger than 20 years with severe aplastic anemia. | 4 |
| 17 | Tissue levels, tissue angiotensin converting enzyme inhibition and antihypertensive effect of the novel antihypertensive agent alacepril in renal hypertensive rats. | 4 |
| 18 | Metabolism of protein conjugate of desacetyl-alacepril and its effect on angiotensin converting enzyme in renal hypertensive rats. | 2 |
| 19 | Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals. | 10 |
| 20 | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.